Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver.
about
Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosisThe shear stress-induced transcription factor KLF2 affects dynamics and angiopoietin-2 content of Weibel-Palade bodies.Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapyRole of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in ratsDevelopment of a synthetic gene network to modulate gene expression by mechanical forces.Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.Potential for statins in the chemoprevention and management of hepatocellular carcinoma.Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects.New cellular and molecular targets for the treatment of portal hypertension.Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.Sinusoidal communication in liver fibrosis and regeneration.How to Face Chronic Liver Disease: The Sinusoidal Perspective.SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis.SP and KLF Transcription Factors in Digestive Physiology and Diseases.A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats.Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies.A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injury.Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers.Enhancing organ pool by statins: is this the future?Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats.Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction.Somatostatin therapy protects porcine livers in small-for-size liver transplantation.Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis.KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.Statins improve NASH via inhibition of RhoA and Ras.Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.Krüppel-like factors: Crippling and un-crippling metabolic pathways.Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectivesSalvianolic Acid A Attenuates Endoplasmic Reticulum Stress and Protects Against Cholestasis-Induced Liver Fibrosis via the SIRT1/HSF1 Pathway
P2860
Q30316703-41B96EDF-958F-4CB8-991C-02A01A68BA50Q34310249-CA16B74E-C265-44B1-A54D-BE60B0979765Q35136411-CEF839B9-5325-4063-A6DF-5CA78CF53D10Q36611305-BB04A1DB-F5E6-48BF-87FB-A8CFF66C3BA7Q36746393-239D9BE0-4C34-43D1-9802-055C7AB2430FQ37084745-2A4FB867-ED33-4BE8-B746-6D5334FC215EQ37899947-FEEB1FB1-C85B-4411-9369-14AB4194195BQ38030991-54AF656D-5DD8-4A58-9A58-7513620880C5Q38100652-5EA6B302-A3C1-4E4E-9EBA-F66FD054B7ABQ38383418-DE81812B-D762-4F13-B8E8-63F7670AEAF6Q38656007-C06C9763-818E-4E6D-9D6B-8536253CFCC4Q38827092-9D64EE53-C8C2-4ABA-A8E7-EB950B0AC4E6Q38940706-92EF3A9E-92EC-41CD-BEBA-4BBC03E58E3BQ39178715-C782CC34-0930-425C-926A-76110B78E420Q39214035-592DC46C-6D67-429C-845A-50FAEB6694E3Q41848559-931F4177-6890-48DE-A1F7-BA79889BB135Q42206856-162EBB2E-5CD8-4651-9B96-332C15D43011Q42223009-CF2F9154-7F4D-441B-9A6E-909EA8AF03E5Q42725673-576F3C52-B6AD-4FD0-B98F-5C10D056C099Q44570493-5DCF01CD-7A68-40DB-BA43-504873C75C9AQ44743116-91AB45DA-9E66-43F7-95EA-49BBB87E2CD5Q45092997-3493AC70-21DE-40CC-B59E-6A66AF628389Q46391156-06A8AA55-8120-4611-805B-9749A92E831CQ46517321-92128C9E-B943-4C62-8C65-0977BAC08FF2Q47580556-647A844F-5833-439A-8D9D-FFA09BB03D0AQ47933874-D4124B2F-1FEF-448A-BDC5-E942FE51C5C0Q48246049-61B1CB60-5081-46FC-9B2E-3A99A848CA80Q48292789-8B8A9ADC-EEBB-4869-9632-545D62E3B125Q48352117-A5380614-4092-4C10-A36A-473691EF37DDQ50441342-DB64A361-E4D5-434A-BBBC-DD7CD691D6AFQ55079168-8CCAF762-BDE2-4CFD-BBA7-7F259A61518EQ58760398-3A95BEDA-4A15-49E2-A0A4-1387C1449775Q59136988-4D6616DF-1CB8-46E3-874C-5236DBC00E3A
P2860
Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Endothelial expression of tran ...... ormal and cirrhotic rat liver.
@en
Endothelial expression of tran ...... ormal and cirrhotic rat liver.
@nl
type
label
Endothelial expression of tran ...... ormal and cirrhotic rat liver.
@en
Endothelial expression of tran ...... ormal and cirrhotic rat liver.
@nl
prefLabel
Endothelial expression of tran ...... ormal and cirrhotic rat liver.
@en
Endothelial expression of tran ...... ormal and cirrhotic rat liver.
@nl
P2093
P356
P1433
P1476
Endothelial expression of tran ...... ormal and cirrhotic rat liver.
@en
P2093
Guillermo García-Cardeña
Héctor García-Calderó
Jaime Bosch
Lucia Russo
P304
P356
10.1136/GUT.2010.220913
P407
P577
2010-11-26T00:00:00Z